Clinical trials
Strabismus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
134 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 5 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 11 |
| 2019 | 8 |
| 2020 | 9 |
| 2021 | 10 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 80 |
| Unknown status | 26 |
| Not yet recruiting | 15 |
| Recruiting | 9 |
| Terminated | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 9 |
| Alaska Blind Child Discovery | 5 |
| Cairo University | 5 |
| Minia University | 5 |
| Rebiscan, Inc. | 5 |
| Assiut University | 4 |
| Jaeb Center for Health Research | 4 |
| Tanta University | 4 |
| Inje University | 3 |
| Sun Yat-sen University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Strabismus | 134 |
| Amblyopia | 32 |
| Exotropia | 13 |
| Esotropia | 12 |
| Emergence Delirium | 9 |
| Anisometropia | 8 |
| Ocular Motility Disorders | 6 |
| Postoperative Nausea and Vomiting | 6 |
| Nystagmus, Pathologic | 4 |
| Bradycardia | 3 |
Trials
Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.
34 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.